SCHEMBL17320604

SCHEMBL17320604

CCc1c[nH]c2ccc(OCc3cc(OC)cc(OC)c3)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.57
HTR1D P28221 6/20 0.55
HTR1A P08908 4/20 0.55
HTR1B P28222 3/20 0.55
HTR2B P41595 1/20 0.55
KDM4E B2RXH2 2/20 0.53
TRPM8 Q7Z2W7 3/20 0.52
MAPT P10636 2/20 0.52
HTR2A P28223 2/20 0.52
CYP2D6 P10635 1/20 0.52
CYP1A2 P05177 1/20 0.52
TSHR P16473 1/20 0.52
NFKB1 P19838 1/20 0.52
HTR2C P28335 1/20 0.52
HTR7 P34969 1/20 0.52
HTR6 P50406 1/20 0.52
HTR4 Q13639 1/20 0.52
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30201905 0.87 KDM4E (0.75) GPR84HTR1DHTR1AHTR1BKDM4E
SCHEMBL15747709 0.87 KDM4E (0.75) GPR84HTR1DHTR1AHTR1BKDM4E
SCHEMBL15747748 0.86 KDM4E (0.59) GPR84HTR1DHTR1AHTR1BHTR2B
SCHEMBL17320607 0.85 KDM4E (0.69) GPR84HTR1DHTR1AHTR1BKDM4E
SCHEMBL178561 0.84 GPR84 (0.78) GPR84HTR1DHTR1AHTR1BHTR2B
SCHEMBL2007192 0.84 TRPM8 (0.72) HTR1DHTR1AHTR1BKDM4ETRPM8
SCHEMBL24493816 0.78 PPARG (0.65) HTR1DHTR1AHTR1BKDM4ETRPM8
SCHEMBL23269429 0.78 HTR1B (0.61) GPR84HTR1DHTR1AHTR1BHTR2B
SCHEMBL23269931 0.77 HTR1B (0.71) GPR84HTR1DHTR1AHTR1BKDM4E
SCHEMBL24493808 0.77 PPARG (0.68) HTR1DHTR1AHTR1BKDM4ETRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10004718-B2 Erythropoietin expression promoter TOHOKU UNIVERSITY (JP) 2018-06-26 US disclosed
US-20150353489-A1 Erythropoietin Expression Promoter KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION KANAGAWA CHILDREN'S MEDICAL CENTER (JP) 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353489-A1 Erythropoietin Expression Promoter EPOR, NFE2L2, FOXO1 GPR84 1199/4885HTR1D 4194/4885HTR1A 3553/4885
US-10004718-B2 Erythropoietin expression promoter EPOR, NFE2L2, FOXO1 GPR84 1199/4885HTR1D 4194/4885HTR1A 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.